- Home
- IPDN vs ENSC Comparison
IPDN vs ENSC Comparison
Compare IPDN & ENSC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IPDN
- ENSC
- Stock Information
- Founded
- IPDN 2003
- ENSC 2003
- Country
- IPDN United States
- ENSC United States
- Employees
- IPDN N/A
- ENSC N/A
- Industry
- IPDN EDP Services
- ENSC Biotechnology: Pharmaceutical Preparations
- Sector
- IPDN Technology
- ENSC Health Care
- Exchange
- IPDN Nasdaq
- ENSC Nasdaq
- Market Cap
- IPDN 4.3M
- ENSC 4.9M
- IPO Year
- IPDN 2013
- ENSC N/A
- Fundamental
- Price
- IPDN $1.68
- ENSC $2.22
- Analyst Decision
- IPDN
- ENSC
- Analyst Count
- IPDN 0
- ENSC 0
- Target Price
- IPDN N/A
- ENSC N/A
- AVG Volume (30 Days)
- IPDN 26.4K
- ENSC 230.3K
- Earning Date
- IPDN 08-12-2025
- ENSC 08-13-2025
- Dividend Yield
- IPDN N/A
- ENSC N/A
- EPS Growth
- IPDN N/A
- ENSC N/A
- EPS
- IPDN N/A
- ENSC N/A
- Revenue
- IPDN $6,508,349.00
- ENSC $6,224,081.00
- Revenue This Year
- IPDN N/A
- ENSC N/A
- Revenue Next Year
- IPDN N/A
- ENSC $1,381.48
- P/E Ratio
- IPDN N/A
- ENSC N/A
- Revenue Growth
- IPDN N/A
- ENSC 256.35
- 52 Week Low
- IPDN $0.97
- ENSC $1.62
- 52 Week High
- IPDN $11.20
- ENSC $14.67
- Technical
- Relative Strength Index (RSI)
- IPDN 48.27
- ENSC 49.53
- Support Level
- IPDN $1.34
- ENSC $2.02
- Resistance Level
- IPDN $1.80
- ENSC $2.30
- Average True Range (ATR)
- IPDN 0.13
- ENSC 0.14
- MACD
- IPDN -0.02
- ENSC 0.02
- Stochastic Oscillator
- IPDN 41.51
- ENSC 43.40
About IPDN Professional Diversity Network Inc.
Professional Diversity Network Inc is engaged in providing access to networking, training, educational and employment services to its registered users. It has three operating segments: the Professional Diversity Network (PDN) segment, which includes online professional networking communities with career resources for diverse cultural groups and employers looking to hire members; and the National Association of Professional Women (NAPW) segment, which is a women-only professional networking organization, the RemoteMore segment. The company generates majority of its revenue from PDN Segment.
About ENSC Ensysce Biosciences Inc.
Ensysce Biosciences Inc is a clinical-stage biotech company using its proprietary technology platforms to develop safer prescription drugs. The company is developing a new class of powerful, tamper-proof opioids that prevent both drug abuse and overdoses. Its products are anticipated to provide safer options to treat severe pain and assist in preventing deaths caused by opioid abuse, reducing human and economic costs. The company's current development pipeline includes two new drug platforms: an abuse-resistant opioid prodrug technology, theTrypsin Activated Abuse Protection, or the TAAP platform, and an over-dose protection opioid prodrug technology, the Multi-Pill Abuse Resistant, or the MPAR platform. The Company currently operates in one business segment, which is pharmaceuticals.